INSPIRing Changes to the IRB Process: New templates and more

Similar documents
When a Single IRB Reviews for Multiple Sites:

Human Subjects Research Policy Update. Naomi Coll Director of Research Policy and Compliance

IRB Application the Basics GETTING STARTED

Privacy Rule Overview

Changes to the Common Rule

APPLICATION FOR RESEARCH REQUESTING AN IRB WAIVER OF CONSENT AND HIPAA AUTHORIZATION

10 STEPS TO IRB APPROVAL

(Type inside gray boxes, cells will expand) A. EIGHT POINT CRITERIA for IRB Review

Setting up a CITI account for users not enrolled at or employed by Georgia Tech. Georgia Institute of Technology December 2016

Utilizing the NCI CIRB

WHAT IS AN IRB? WHAT IS AN IRB? 3/25/2015. Presentation Outline

IRB Survival Guide! Getting Approved

DANA-FARBER / HARVARD CANCER CENTER POLICIES FOR HUMAN SUBJECT RESEARCH TITLE:

eirb Review Checklist

Final Rule Material: Overview

UA New Common Rule Implementation

REGULATORY AND FUNDING CHANGES FOR HUMAN SUBJECTS RESEARCH

The Revised Common Rule

Overview of the Revised Common Rule

Summary of the Common Rule Changes

IRB 101. Rachel Langhofer Joan Rankin Shapiro Research Administration UA College of Medicine - Phoenix

Common Rule Overview (Final Rule)

NEWCASTLE CLINICAL TRIALS UNIT STANDARD OPERATING PROCEDURES

DO I NEED TO SUBMIT FOR THIS?... & OTHER FREQUENTLY ASKED QUESTIONS. March 2015 IRB Forum

ClinicalTrials.gov workshop

Frequently Asked Questions. The CIRB is located at 168 Jalan Bukit Merah #06-08 Tower 3 Connection One Singapore

UConn Health Office of Clinical & Translational Research Standard Operating Procedures

LifeBridge Health HIPAA Policy 4. Uses of Protected Health Information for Research

The Queen s Medical Center HIPAA Training Packet for Researchers

Good Documentation Practices. Human Subject Research. for

Loyola University Chicago Health Sciences Division Maywood, IL. Human Subject Research Project Start-Up Guide

INSTITUTIONAL REVIEW BOARD Investigator Guidance Series HIPAA PRIVACY RULE & AUTHORIZATION THE UNIVERSITY OF UTAH. Definitions.

Authorization and Waiver Frequently Asked Questions

New HIPAA Privacy Regulations Governing Research. Karen Blackwell, MS Director, HIPAA Compliance

Section 11. Recruitment of Study Subjects (Revised 7/1/10)

USING SMART IRB AND SINGLE IRB REVIEW

AN OVERVIEW OF CLINICAL STUDY TASKS AND ACTIVITIES

Instructions for Submission: Research Grant Applications National Multiple Sclerosis Society 2018

Human Subject Regulations Decision Charts

12.0 Investigator Responsibilities

Guide to Completing Medical University of South Carolina s Institutional Review Board (IRB) Continuing Review Application

The LOI is only to allow organization of the review process, and all projects submitting an LOI will be permitted to submit a full application.

Research Audits PGR. Effective: 12/04/2013 Reviewed: 12/04/2015. Name of Associated Policy: Palmetto Health Administrative Research Review

CROHN S & COLITIS FOUNDATION OF AMERICA INSTRUCTIONS. Effective November 2009

Office of Human Research Office of Human Research Policy and Procedure Manual. Version: 4/4/18

HIPAA Privacy Regulations Governing Research

Privacy Board Standard Operating Procedures

IRB Process for SURF April 21, 2015

USF HRPP Updates October 2017

Dr. R. Sathianathan. Role & Responsibilities of Principal Investigators in Clinical Trials. 18 August 2015

FORM A APPLICATION FORM A TENNESSEE WESLEYAN UNIVERSITY. Application for Review of Research Involving Human Subjects

Institutional Review Board Standard Operating Procedures. Education and Training on Human Subject Research Date Last Revised: OVERVIEW

DANA-FARBER / HARVARD CANCER CENTER STANDARD OPERATING PROCEDURES FOR HUMAN SUBJECT RESEARCH

The SOP applies to all human subject research falling under the purview of the University of Missouri Institutional Review Board.

Local VA VA ORD CSP Other VA ORD. IRB of Record Registration Number: IRB Operated by: Local VA Non-local VA Academic Affiliate VHA Central IRB

Waiver of Informed Consent when Using Medical Records or Other Secondary Data or Specimens UNC-CH OHRE Guidance Document

Navigating HIPAA Regulations. Michelle C. Stickler, DEd Director, Research Subjects Protections

Demystifying the IRB

A Principal Investigator s Guide to Responsibilities, Qualifications, Records and Documentation of Human Research University of Kentucky

SAINT AGNES MEDICAL CENTER CLINICAL RESEARCH CENTER Fresno, California. STANDARD OPERATING PROCEDURES Institutional Review Board

Pilot & Collaborative Studies (PCS) Funding Program FAQs

ETHICAL AND REGULATORY CONSIDERATIONS

UT Southwestern Medical Center Human Research Protection Program Policy, Procedure and Guidance Documents

The Impact of The HIPAA Privacy Rule on Research

Ask the Experts Panel

BANKS ON BANKS. Clinical Research Seminar March 20, 2013 Mary A. Banks Director BUMC IRB

The Greenville Hospital System Office of Research Compliance and Administration HRPP Policies and Procedures

Informed Consent Template for Participating in Tay-Sachs and Sandhoff Disease Registry

SPH Seed Funding Program

Childhood Cancer Research Seed Grants Full Proposal Application Guidelines

Frequently Asked Questions (FAQs) for the ACG Clinical Research Awards:

TRIAL INNOVATION NETWORK Key Terminology and Definitions

Clinical Research Resources Office ReSPECT Registry & StudyFinder at BU/BMC

Peeling Back the Layers of a Waiver of Informed Consent

YALE UNIVERSITY THE RESEARCHERS GUIDE TO HIPAA. Health Insurance Portability and Accountability Act of 1996

Standard Operating Procedure IRB Review of Research Subject to the Revised Common Rule

PFF Patient Registry Protocol Version 1.0 date 21 Jan 2016

Grambling State University Application for Human Subjects Review IRB Protocol. 1. Principal Investigator [Last Name, First Name, Middle Initial]

TABLE OF CONTENTS Guidelines About the Leukemia & Lymphoma Society Description of Awards Who Can Apply General Eligibility Criteria

SAMPLE. RISE Data Use Request Form - Academic. Step 1 - Contact Information. Who will serve as the point of contact for this project?

New Study Submissions to the IRB

Postdoctoral Fellowships ( )

Institutional Review Board Application for Exempt Status Determination

CLINICAL RESEARCH GRANT PROGRAM GUIDELINES

Faculty of Law Ethical Standards Sub-Committee ETHICAL CLEARANCE POLICY AND PROCEDURES

The Clinical Research Center Research Practice Manual. Guideline for Study Document and Data Handling RPG-08. Guideline. Purpose.

The Clinical Investigation Policy and Procedure Manual Document: CIPP

Common Pitfalls to the Non-Course-Based Research IRB Application. Revised December, 2013

1. Applicant Name: (Please check one) [ ]Insured/Patient [ ]Patient s Designee [ ]Provider. 2. Patient Name: 3. Patient Address:

Approval of your study will expire at the end of the day (midnight) on August 2, 2016.

Frequently Asked Questions (FAQs) for the ACG Clinical Research Awards:

"Getting Your Protocol Through the IRB"

IRB review of international research. Pre-conference P1 FCPA 3 rd Party Due Diligence for Health Entities. Today

Ethics Committee Composition Roles & Responsibilities. Dr Girish Dayma Dr Sanjay Juvekar KEM Hospital Research Centre Pune

7/1/16 - until amended - 9.1%

Clinical Investigator Career Development Award ( )

Resource Document for IRB members

1. Contacts and Title

University of South Carolina. Unanticipated Problems and Adverse Events Guidelines

IN ACCORDANCE WITH THIS INTERNATIONAL DEVICE STANDARD

Transcription:

INSPIRing Changes to the IRB Process: New templates and more John F. Ennever, MD, PhD, CIP Director, Human Research Protection Program Office of Human Research Affairs Boston Medical Center and Boston University Medical Campus

Learning objectives List 3 major changes in policy effective November 1, 2016. Describe the process within INSPIR for including a separate protocol. Describe the new policy regarding limited and non-readers, including requirements in the informed consent form and when existing studies have to come into compliance. 2

New Policies as of November 1 affecting only NEW submissions (1) Initial submissions of clinical trials that involve a drug, device, or surgical intervention must have a detailed protocol Sponsor or cooperative group protocol, or Local PI-written based upon template posted on our website 3

New Policies as of November 1 affecting only NEW submissions (2) Initial submissions must use new consent form template Sponsor-provided consent forms must use new header and have required information on the first page 4

New Policies as of November 1 affecting only NEW submissions (3) Study staff on all initial submissions of biomedical clinical trials must complete GCP (good clinical practice) training CITI, CRRO training, or sponsor training 5

New Policies as of November 1 affecting ALL submissions Plans for findings with potential health or reproductive importance (pertinent and/or incidental findings) must be described Inclusion or exclusion of limited- and non-readers must be specified Default position is to include and this requires a witness line on consent form 6

What in INSPIR has changed? Part 1: New Pathways (1) An abbreviated pathway when a separate detailed protocol is attached (a requirement for new biomedical clinical trials) Acceptable protocols: sponsor, cooperative group, ones based upon our template or one of the NIH templates NOT Acceptable: Grant application 7

8

What in INSPIR has changed? Part 1: New Pathways (2) Abbreviated pathway for chart reviews If no external funding, exempt under equivalent protections With funding and retrospective only, exempt category 4 With funding and includes prospective, expedited with waiver of consent. 9

10

What in INSPIR has changed? Part 2: New Process (3) Short Forms Investigator requests specific languages (no change) IRB approves use of specific languages (no change) IRB staff upload approved (stamped) short forms (with PI name, telephone number filled in) into consent form section (new) IRB staff upload additional page for signatures of witness and person obtaining consent; page is signed and appended to existing English-language consent form when short form is used (new) 11

12

What in INSPIR has changed? Part 3: Modified Questions (1) Plan for the return of subject level findings Before: Asked if study results would be returned: if no, no other questions; if yes, asked to explain how Now: Asks if the study could yield findings of potential health or reproductive importance (pertinent and/or incidental findings): if no, no other questions; if yes, asked to explain plan to return or reasons not to do so. 13

What in INSPIR has changed? Part 3: Modified Questions (2) Inclusion of limited- and non-readers Before: Limited- and non-readers were one of a dozen special populations, no directions for witness signatures in consent form Now: Specific question about limited- and non-readers; if no, justify exclusion; if yes, consent form must include (or has been read to me) and place for witness signature. 14

15

What in INSPIR has changed? Part 3: Modified Questions (3) Screening processes Before: Screening questions only had to be answered if sensitive identifiable information was being kept or clinical procedures just for screening. Now: Screening questions (including provisions for abbreviated consent ) must be answered if screening involves any interaction with potential subjects. 16

What in INSPIR has changed? Part 4: Previously Optional Questions, Now Required Four questions were optional when first introduced, now are required PI confirming human subjects training and filing Conflict of Interest forms Privacy protections PI confirming no recruitment incentives Whether a repository stores genetic information 17

What in INSPIR has changed? Part 5: Lower-Impact Changes Exempt submissions must provide a lay summary Cede requests have new questions about local policies Drug and device studies have new and reworded questions Not Human Subjects Research submissions answer whether the study meets the definition of research Studies recruiting from Community Health Centers have specific guidance 18

More Information 19

How you will recognize the new INSPIR 20

Thank you! 21